| Axis of evil: molecular mechanisms of cancer metastasis T Bogenrieder, M Herlyn Oncogene 22 (42), 6524-6536, 2003 | 839 | 2003 |
| Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression CN Papandreou, B Usmani, Y Geng, T Bogenrieder, R Freeman, S Wilk, ... Nature medicine 4 (1), 50-57, 1998 | 342 | 1998 |
| Melanoma–stroma interactions: structural and functional aspects D Ruiter, T Bogenrieder, D Elder, M Herlyn The Lancet Oncology 3 (1), 35-43, 2002 | 294 | 2002 |
| Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors L Ireland, A Santos, MS Ahmed, C Rainer, SR Nielsen, V Quaranta, ... Cancer research 76 (23), 6851-6863, 2016 | 257 | 2016 |
| Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil G Li, K Satyamoorthy, F Meier, C Berking, T Bogenrieder, M Herlyn Oncogene 22 (20), 3162-3171, 2003 | 208 | 2003 |
| Differential response of primary and metastatic melanomas to neutrophils attracted by IL‐8 H Schaider, M Oka, T Bogenrieder, M Nesbit, K Satyamoorthy, C Berking, ... International Journal of Cancer 103 (3), 335-343, 2003 | 188 | 2003 |
| Insulin-like growth factor (IGF) pathway targeting in cancer: role of the IGF axis and opportunities for future combination studies A Simpson, W Petnga, VM Macaulay, U Weyer-Czernilofsky, ... Targeted oncology 12, 571-597, 2017 | 165 | 2017 |
| Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer: a randomized multicenter phase II trial of the North-Eastern German … J Sehouli, D Stengel, P Harter, C Kurzeder, A Belau, T Bogenrieder, ... Journal of Clinical Oncology 29 (2), 242-248, 2011 | 125 | 2011 |
| Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue T Bogenrieder, CL Finstad, RH Freeman, CN Papandreou, HI Scher, ... The Prostate 33 (4), 225-232, 1997 | 110 | 1997 |
| Reciprocal regulation of MelCAM and AKT in human melanoma G Li, J Kalabis, X Xu, F Meier, M Oka, T Bogenrieder, M Herlyn Oncogene 22 (44), 6891-6899, 2003 | 108 | 2003 |
| Orofacial granulomatosis as the initial presentation of Crohn’s disease in an adolescent T Bogenrieder, G Rogler, T Vogt, M Landthaler, W Stolz Dermatology 206 (3), 273-278, 2003 | 95 | 2003 |
| Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II T Vogt, M McClelland, B Jung, S Popova, T Bogenrieder, B Becker, ... Melanoma research 11 (6), 587-599, 2001 | 85 | 2001 |
| Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. AD Hoffman, D Engelstein, T Bogenrieder, CN Papandreou, ... Clinical cancer research: an official journal of the American Association …, 1996 | 84 | 1996 |
| Wells’ syndrome associated with idiopathic hypereosinophilic syndrome T Bogenrieder, DP Griese, R Schiffner, R Büttner, GAJ Riegger, ... British Journal of Dermatology 137 (6), 978-982, 1997 | 82 | 1997 |
| Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer L Ireland, A Santos, F Campbell, C Figueiredo, D Hammond, LG Ellies, ... Oncogene 37 (15), 2022-2036, 2018 | 70 | 2018 |
| No longer a molecular black box–new clues to apoptosis and drug resistance in melanoma K Satyamoorthy, T Bogenrieder, M Herlyn Trends in Molecular Medicine 7 (5), 191-194, 2001 | 67 | 2001 |
| Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma T Bogenrieder, M Herlyn Critical reviews in oncology/hematology 44 (1), 1-15, 2002 | 66 | 2002 |
| Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases C Girlich, T Bogenrieder, KD Palitzsch, J Schölmerich, G Lock European journal of gastroenterology & hepatology 14 (8), 873-876, 2002 | 61 | 2002 |
| Nuclear IGF1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage T Aleksic, N Gray, X Wu, G Rieunier, E Osher, J Mills, C Verrill, RJ Bryant, ... Cancer research 78 (13), 3497-3509, 2018 | 59 | 2018 |
| Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease small-cell lung cancer: final results of a randomized phase … TH Fink, RM Huber, DF Heigener, C Eschbach, C Waller, EU Steinhauer, ... Journal of Thoracic Oncology 7 (9), 1432-1439, 2012 | 59 | 2012 |
